K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce financial results for the three and ...

The Tenth Circuit’s ruling allows the defunct LTL carrier to amend its complaint, alleging the Teamsters’ refusal to support ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt.

IBM has announced major progress in quantum computing development, unveiling new processor technology and setting ambitious ...

Researchers are cultivating human brain cells in laboratories to transform them into biological circuits for creating ...

Aalto University has demonstrated Tensor calculations using light. “Tensor operations are the kind of arithmetic that form ...

While working in an electrically safe work condition is important, there are times when working hot is necessary. Make sure ...

October 31, 2025 @ Laser Focus World - In this episode: Immersive 3D via an ultrathin display, the latest business news ...

The year isn't over yet, but we've already seen record-breaking quantum computers, skyrocketing levels of investment, and demonstrations of real-world benefits.

Ionis has committed to a phase 3 programme for its antisense therapy for rare genetic disorder Angelman syndrome, just weeks after Biogen decided against exercising an option to license the drug. The ...